Events

Cluster 5 2026 call European Commission online Brokerage event and info day
JAN
Wed
14
JAN
Thu
15

This was 4 months ago

Location

online

Programmes
Climate, Energy, Mobility

Join the Horizon Europe Cluster 5 info day on 15 January 2026 to explore the 2026 topics of the forthcoming work programme 2026-2027. This online event will be streamed via the European Commission’s web platform.

What to expect

  • Insights into the policy context

  • Guidance for preparing a high-quality proposal

  • Tips for enhancing the role of Social Sciences and Humanities in relevant topics

  • Interactive parallel sessions by thematic area to address specific questions on the topics

Here you can find more information on the event and register

The official publication of the Cluster 5 work programme 2026-2027 is expected any day now (estimated budget of €1.2 billion for the 2026 calls). A pre-publication version is already available.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.